Open AccessA randomized, double-blind trial of amorolfine 0.25% cream and sertaconazole 2% cream in limited dermatophytosis
Author(s) -
Anirban Das,
Abheek Sil,
Tushar Kanti Sarkar,
Arpita Sen,
Sriparna Chakravorty,
Mallika Sengupta,
Anupam Das,
Somodyuti Chandra,
Santasmita Pal,
Debabrata Bandyopadhyay,
Nilay Kanti Das
Publication year - 2019
Publication title -
indian journal of dermatology, venereology, and leprology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.514
H-Index - 45
eISSN - 0973-3922
pISSN - 0378-6323
DOI - 10.4103/ijdvl.ijdvl_907_17
Subject(s) - medicine , adverse effect , dermatology , tinea capitis , erythema , randomized controlled trial , antifungal , clinical trial
Dermatophytosis is becoming increasingly unresponsive to conventional antifungals. Newer topical antifungals may be more effective in these patients.